DERM vs SNPS · rev $34.5M vs P/E 63, rev $7.16B
Journey Medical Corp (DERM) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
DERM currently screens at market cap $163.1M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the DERM and SNPS stock pages for the full models.
Not investment advice.